DEPT OF DEFENSE has floated a tender for Budesonide Inhalation Suspension. The project location is USA and the tender is closing on 25 Apr 2024. The tender notice number is Solicitation_SPE2D224R0005, while the TOT Ref Number is 99956823. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : USA

Summary : Budesonide Inhalation Suspension

Deadline : 25 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 99956823

Document Ref. No. : Solicitation_SPE2D224R0005

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : DEPT OF DEFENSE
Contracting Office Address : PHILADELPHIA, PA 19111
Primary Point of Contact : Nancy Fernandez
nancy.fernandez@dla.mil
Phone Number 215-737-4955

Secondary Point of Contact : Catherine Gilbert
catherine.gilbert@dla.mil
Phone Number 2157374778
USA
Email :nancy.fernandez@dla.mil

Tender Details

Description

See attachment.
Active Contract Opportunity Notice ID Solicitation_SPE2D224R0005 Related Notice SPE2D2-24-R-0005 Department/Ind. Agency DEPT OF DEFENSE Sub-tier DEFENSE LOGISTICS AGENCY Major Command TROOP SUPPORT MEDICAL Office DLA TROOP SUPPORT
General Information
Contract Opportunity Type: Solicitation (Updated)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Updated Published Date: Apr 10, 2024 03:33 pm EDT
Original Published Date: Mar 12, 2024 09:05 am EDT
Updated Date Offers Due: Apr 25, 2024 03:00 pm EDT
Original Date Offers Due: Apr 11, 2024 03:00 pm EDT
Inactive Policy: Manual
Updated Inactive Date: Apr 25, 2029
Original Inactive Date: Apr 12, 2029
Initiative: None

Classification
Original Set Aside:

Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing

Place of Performance:

Documents

 Tender Notice

SPE2D224R00050002_Amendment-0002-for-Budesonide.pdf

Updated-Schedule-of-Supplies.pdf

SPE2D224R00050001.PDF

Solicitation_Budesonide-National-Contract_SPE2D224R0005_updated-12.March.2024.pdf